Calls
1
Ariana Sarin
CFO, AstraZeneca
Win Rate
100.0%
return
+0.4%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jul 27
$171.73
+0.4%
AstraZeneca is on track for its $80 billion revenue target by 2030, driven by oncology growth, diversified pipeline, and high phase 3 trial success rates; consensus revenue estimates are now above $80 billion, and the company plans sustained R&D investment to maintain 5% growth beyond 2030.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Ariana Sarin has 1 trade ideas tracked on Buzzberg across 1 tickers since July 2026. Most covered: AZN.
